Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin

Pediatric Transplantation

Volumn 16, Issue 8, 2012, Pages

  Keck, Megan ^a   Mindru, Cezarina ^a   Kalil, Andre C ^a   Mercer, David F ^a   Florescu, Diana F ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

pediatric liver transplantation; respiratory syncytial virus; treatment

Indexed keywords

ACICLOVIR; BRONCHODILATING AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; RIBAVIRIN; TACROLIMUS; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ANEMIA; ANTIVIRAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; ATELECTASIS; BACTERIAL INFECTION; BLOOD PRESSURE; BODY TEMPERATURE; BREATHING RATE; CASE REPORT; CHILD; COUGHING; CYTOMEGALOVIRUS INFECTION; END STAGE LIVER DISEASE; EXTUBATION; FEVER; GASTROINTESTINAL SYMPTOM; GESTATIONAL AGE; GRAFT RECIPIENT; HEART RATE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOWER RESPIRATORY TRACT INFECTION; LUNG INFILTRATE; LUNG LAVAGE; MALE; MONOCYTE; NECROTIZING ENTEROCOLITIS; OXYGEN CONSUMPTION; OXYGEN SATURATION; OXYGEN THERAPY; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INTUBATION; SECONDARY INFECTION; SMALL INTESTINE RESECTION; TACHYPNEA; THORAX RADIOGRAPHY; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION;

ADMINISTRATION, ORAL; AEROSOLS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIVIRAL AGENTS; CHILD, PRESCHOOL; HUMANS; LIVER TRANSPLANTATION; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RIBAVIRIN;

EID: 84868697223     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2012.01700.x     Document Type: Article

References (19)

1. Peters TR, Crowe JE Jr,. Respiratory syncytial virus. In:, Long SS, ed. Principles and Practice of Pediatric Infectious Disease, 3rd edn. Philadelphia, PA: Churchill Livingstone, 2008: pp. 1112-1117.
2. Wright M, Piedimonte G,. Respiratory syncytial virus prevention and therapy: Past, present, and future. Pediatr Pulmonol 2011: 46: 324-347.
3. Kim YJ, Boeckh M, Englund JA,. Community respiratory virus infections in immunocompromised patients: Hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med 2007: 28: 222-242.
4. Ison MG, Hayden FG,. Viral infections in immunocompromised patients: What's new with respiratory viruses? Curr Opin Infect Dis 2002: 15: 355-367.
5. Avetisyan G, Mattsson J, Sparrelid E, Ljungman P,. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: A retrospective study of the incidence, clinical features, and outcome. Transplantation 2009: 88: 1222-1226.
6. Khanna N, Widmer AF, Decker M, et al., Respiratory syncytial virus infection in patients with hematological diseases: Single-center study and review of the literature. Clin Infect Dis 2008: 46: 402-412.
7. Ariza-Heredia EJ, Fishman JE, Cleary T, Smith L, Razonable RR, Abbo L,. Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: A single-center experience. Transpl Infect Dis 2012: 14: 64-71.
8. Pohl C, Green M, Wald ER, Ledesma-Medina J,. Respiratory syncytial virus infections in pediatric liver transplant recipients. J Infect Dis 1992: 165: 166-169.
9. Groothuis JR, Gutierrez KM, Lauer BA,. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 1988: 82: 199-203.
10. Milstone AP, Brumble LM, Barnes J, et al., A single-season prospective study of respiratory viral infections in lung transplant recipients. Eur Respir J 2006: 28: 131-137.
11. Ison MG, Michaels MG, AST I nfectious D iseases C ommunity of P ractice. RNA respiratory viral infections in solid organ transplant recipients. Am J Transplant 2009: 9 (Suppl 4): S166-S172.
12. Whimbey E, Champlin RE, Englund JA, et al., Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995: 16: 393-399.
13. Anak S, Atay D, Unuvar A, et al., Respiratory syncytial virus infection outbreak among pediatric patients with oncologic diseases and/or BMT. Pediatr Pulmonol 2010: 45: 307-311.
14. Varizole Package Insert. Aliso Viejo, CA: Valeant, 2008 [cited 2010]. http://www.valeant.com/fileRepository/products/PI/Virazole- Inhalation%20Solution%206gm-PI-Apr02.pdf (accessed July 30, 2011).
15. Pelaez A, Lyon GM, Force SD, et al., Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. J Heart Lung Transplant 2009: 28: 67-71.
16. Chakrabarti S, Collingham KE, Holder K, Fegan CD, Osman H, Milligan DW,. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: A pilot study. Bone Marrow Transplant 2001: 28: 759-763.
17. Mori T, Nakamura Y, Kato J, et al., Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. Int J Hematol 2011: 93: 132-134.
18. Koren G, King S, Knowles S, Phillips E,. Ribavirin in the treatment of SARS: A new trick for an old drug? CMAJ 2003: 168: 1289-1292.
19. Connor E, Morrison S, Lane J, Oleske J, Sonke RL, Connor J,. Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection. Antimicrob Agents Chemother 1993: 37: 532-539.